← Diagnosis and Management Guides
Pulmonary Embolism
Key considerations: Massive PE with hemodynamic collapse, Saddle PE, Right heart failure from PE
Cannot miss
- Massive PE with hemodynamic collapse
- Saddle PE
- Right heart failure from PE
- Paradoxical embolism (stroke via PFO)
Likely diagnoses
- Subsegmental PE
- DVT without PE
- Pneumonia
- Pleurisy
- Musculoskeletal chest pain
- Anxiety
Red flags
- Hypotension (SBP <90)
- Syncope
- Tachycardia with hypoxia
- RV dilation on echo or CT
- Elevated troponin or BNP
- Bilateral leg swelling
- Cancer with new dyspnea
Workup
- history: Risk factors: recent surgery, immobilization, travel >4 hrs, hormonal contraception, cancer, prior VTE; Symptoms: pleuritic chest pain, dyspnea (acute onset), hemoptysis, unilateral leg pain/swelling; Onset: typically sudden; Family history of VTE or thrombophilia; exam: Tachycardia, tachypnea, hypoxia; Unilateral leg swelling, calf tenderness, palpable cord (DVT); JVD, RV heave (right heart strain); Loud P2 (pulmonary hypertension); Clear lung exam is common with PE; labs: D-dimer (age-adjusted: age × 10 for patients >50); Troponin (RV strain marker — prognostic); BNP/NT-proBNP (prognostic); CBC, BMP, coagulation studies; ABG: hypoxia, respiratory alkalosis, increased A-a gradient; imaging: CT Pulmonary Angiography (CTPA) — gold standard; Lower extremity duplex ultrasound if CTPA contraindicated; V/Q scan if contrast allergy or renal impairment; CXR: often normal — Hampton hump, Westermark sign (rare); bedside: ECG: sinus tachycardia most common, S1Q3T3 (classic but uncommon), RV strain, new RBBB; Bedside echo: RV dilation, RV hypokinesis, McConnell sign, D-shaped septum; Compression ultrasound of legs: DVT present in ~50% of PE patients
Management
- immediate: Apply Wells PE score or PERC rule to determine pretest probability; If low probability and PERC-negative: PE effectively ruled out; If low probability and PERC-positive: check D-dimer; If moderate-high probability: proceed directly to CTPA; general: Anticoagulation: start immediately if high clinical suspicion, even before imaging; Heparin drip or enoxaparin 1mg/kg BID; Monitor for hemodynamic deterioration; specific: diagnosis: Low-Risk PE (Hemodynamically Stable); steps: Anticoagulation with LMWH or heparin → transition to DOAC; Consider outpatient management with DOAC if low PESI score and reliable follow-up; Duration: 3–6 months minimum, indefinite if unprovoked or recurrent; diagnosis: Submassive PE (RV Strain); steps: Heparin drip; Close monitoring in ICU or step-down; Consider catheter-directed therapy or systemic thrombolysis if deteriorating; Cardiology/pulmonology consult; diagnosis: Massive PE (Hemodynamic Instability); steps: Systemic tPA: alteplase 100mg IV over 2 hours; Bolus heparin; Aggressive IV fluids (500mL bolus — avoid overloading RV); Vasopressors: norepinephrine preferred; Consider surgical embolectomy or catheter-directed therapy if tPA contraindicated
Disposition
- admit: All massive and submassive PE — ICU; First-time PE requiring anticoagulation initiation; Significant comorbidities or poor social support; Elevated troponin or BNP; discharge: Low-risk PE with PESI class I-II; Adequate social support and follow-up; Can take oral anticoagulation; Hestia criteria met for outpatient management; consults: Pulmonology/Hematology: recurrent PE, thrombophilia workup; Interventional radiology: catheter-directed therapy; Cardiac surgery: surgical embolectomy for massive PE with tPA contraindication
Clinical pearls
- PERC rule: if ALL 8 criteria are negative AND low pretest probability, PE is ruled out without D-dimer
- Age-adjusted D-dimer cutoff for patients >50: age × 10 ng/mL (e.g., 65yo → cutoff 650)
- A clear lung exam with hypoxia should raise suspicion for PE
- Massive PE: give tPA even during CPR if PE is the suspected cause of arrest
- In pregnancy: CTPA preferred over V/Q scan — fetal radiation dose is lower
- Never delay anticoagulation while waiting for imaging if clinical suspicion is high
Source and review
- AHA PE Guidelines 2019, ESC PE Guidelines 2019, ACEP Clinical Policy PE 2018. Last reviewed: 2024-11-01